Qrons Inc. Stock Price - QRON

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Qrons Inc. QRON Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.43 -22.75% 1.46 2.00 1.46 1.90 1.89 16:27:27
Bid Price Ask Price Spread Spread % News
1.32 2.04 0.72 35.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6 1,050 $ 1.6493 $ 1,732 210 0.72 - 3.90
Last Trade Time Type Quantity Stock Price Currency
14:00:51 250 $ 1.46 USD

Qrons Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 18.93M 12.97M $ -3.93M - -4.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
100.00 $ - 0.00% - -

more financials information »

Qrons Inc. News

Latest QRON Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QRON Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.8721.451.6640333-0.41-21.93%
1 Month1.2521.251.43807110.2116.80%
3 Months1.221.21.37346340.2621.67%
6 Months1.252.050.721.29676980.2116.80%
1 Year23.90.722.12991k-0.54-27.00%
3 Years13.90.722.19001k0.4646.00%
5 Years13.90.722.19001k0.4646.00%

Qrons Inc. Description

The company is a startup preclinical stage biotechnology company engaged in developing solutions to combat neuro-degenerative diseases and neuronal injuries. The company is working to develop a novel stem cell system to repair and regenerate neuronal damage. The system incorporates what we believe to be unique stem cell treatments, cell modifications and a novel delivery system. Our preliminary focus is on Traumatic Brain Injury, Parkinson's disease, Huntington's disease and Alzheimer's, although we believe such cell system can be effective in dealing with strokes and spinal cord injuries as well.


Your Recent History
USOTC
QRON
Qrons Inc.
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.